SAN DIEGO (AP) _ Turning Point Therapeutics Inc. (TPTX) on Tuesday reported a loss of $66.3 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of $1.34.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.26 per share.

The biopharmaceutical company posted revenue of $460,000 in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TPTX at https://www.zacks.com/ap/TPTX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News